Evaluation of the Effectiveness of iPACK and Adductor Canal Blocks on Patients Undergoing Arthroscopic Knee Surgery
Launched by SAKARYA UNIVERSITY · May 24, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two specific pain management techniques, called the IPACK block and the adductor canal block, to see how well they help patients recover after having arthroscopic knee surgery. This type of surgery is very common, but many patients experience significant pain afterward, which can slow down recovery and lead to other health issues. By testing these pain relief methods, the researchers hope to find ways to improve recovery quality for patients.
To participate in the study, you need to be between 18 and 50 years old and scheduled for knee surgery using spinal anesthesia. You should be in good health according to the American Society of Anesthesiologists' classification, which assesses medical risks. Unfortunately, if you have certain health conditions, like bleeding disorders, or if you are not able to cooperate during the study, you wouldn’t be eligible. If you join the trial, you can expect to receive one of the pain management techniques and help researchers understand which method works best for recovery after knee surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged between 18 and 50 years,
- • Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology
- • Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification
- Exclusion Criteria:
- • Coagulopathy
- • ASA IV-V patients
- • Uncooperable patients
- • Patients who refuses to participate in study
- • Patients who takes chronic pain treatments
About Sakarya University
Sakarya University is a distinguished academic institution dedicated to advancing scientific research and innovation in healthcare. With a robust commitment to improving patient outcomes, the university actively sponsors clinical trials that explore novel therapeutic approaches and contribute to evidence-based medicine. Leveraging a multidisciplinary team of researchers, clinicians, and scholars, Sakarya University fosters a collaborative environment aimed at enhancing clinical practices and addressing pressing health challenges. Through these initiatives, the university not only enriches the academic landscape but also plays a pivotal role in translating research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sakarya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported